Wolverine Trading’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.53M | Buy |
83,167
+51,783
| +165% | +$4.1M | ﹤0.01% | 1321 |
|
|
2025
Q2 | $2.71M | Buy |
31,384
+13,001
| +71% | +$1.02M | ﹤0.01% | 1465 |
|
|
2025
Q1 | $1.25M | Sell |
18,383
-512
| -3% | -$41.8K | ﹤0.01% | 2046 |
|
|
2024
Q4 | $1.47M | Buy |
18,895
+10,289
| +120% | +$762K | ﹤0.01% | 2268 |
|
|
2024
Q3 | $579K | Sell |
8,606
-7,657
| -47% | -$629K | ﹤0.01% | 2919 |
|
|
2024
Q2 | $1.84M | Buy |
+16,263
| New | +$2.06M | ﹤0.01% | 1673 |
|
|
2024
Q1 | – | Sell |
-2,114
| Closed | -$266K | – | 4686 |
|
|
2023
Q4 | $262K | Buy |
+2,114
| New | +$216K | ﹤0.01% | 3591 |
|
|
2023
Q3 | – | Sell |
-7,798
| Closed | -$879K | – | 4637 |
|
|
2023
Q2 | $998K | Buy |
+7,798
| New | +$943K | ﹤0.01% | 2013 |
|
|
2023
Q1 | – | Sell |
-101,686
| Closed | -$11.4M | – | 4403 |
|
|
2022
Q4 | $11.5M | Buy |
101,686
+33,920
| +50% | +$3.72M | 0.02% | 567 |
|
|
2022
Q3 | $5.56M | Buy |
67,766
+22,960
| +51% | +$1.94M | 0.01% | 791 |
|
|
2022
Q2 | $3.38M | Sell |
44,806
-20,270
| -31% | -$1.85M | 0.01% | 1011 |
|
|
2022
Q1 | $8.44M | Sell |
65,076
-41,616
| -39% | -$4.55M | 0.01% | 769 |
|
|
2021
Q4 | $14.4M | Sell |
106,692
-117,480
| -52% | -$16.9M | 0.02% | 572 |
|
|
2021
Q3 | $30.6M | Buy |
224,172
+97,692
| +77% | +$12.3M | 0.03% | 373 |
|
|
2021
Q2 | $13.5M | Buy |
126,480
+45,592
| +56% | +$4.38M | 0.02% | 565 |
|
|
2021
Q1 | $7.02M | Buy |
80,888
+36,292
| +81% | +$3.41M | 0.01% | 901 |
|
|
2020
Q4 | $4.04M | Buy |
44,596
+35,956
| +416% | +$3.21M | 0.01% | 1216 |
|
|
2020
Q3 | $869K | Sell |
8,640
-30,576
| -78% | -$3.19M | ﹤0.01% | 2213 |
|
|
2020
Q2 | $3.9M | Sell |
39,216
-968
| -2% | -$86.6K | 0.01% | 949 |
|
|
2020
Q1 | $2.79M | Buy |
40,184
+24,184
| +151% | +$1.5M | 0.01% | 1094 |
|
|
2019
Q4 | $865K | Buy |
+16,000
| New | +$759K | ﹤0.01% | 2552 |
|
|
2019
Q1 | – | Sell |
-29,608
| Closed | -$1.04M | – | 4686 |
|
|
2018
Q4 | $876K | Buy |
+29,608
| New | +$939K | ﹤0.01% | 2084 |
|
|
2018
Q3 | – | Sell |
-25,264
| Closed | -$783K | – | 5114 |
|
|
2018
Q2 | $468K | Hold |
25,264
| – | – | ﹤0.01% | 3168 |
|
|
2018
Q1 | $468K | Buy |
25,264
+6,204
| +33% | +$91.7K | ﹤0.01% | 3168 |
|
|
2017
Q4 | $273K | Sell |
19,060
-24,496
| -56% | -$318K | ﹤0.01% | 3751 |
|
|
2017
Q3 | $533K | Buy |
43,556
+26,592
| +157% | +$470K | ﹤0.01% | 2538 |
|
|
2017
Q2 | $311K | Buy |
+16,964
| New | +$313K | ﹤0.01% | 2985 |
|
|
2017
Q1 | – | Sell |
-53,976
| Closed | -$806K | – | 4412 |
|
|
2016
Q4 | $806K | Buy |
+53,976
| New | +$956K | ﹤0.01% | 2128 |
|
Other funds holding DXCM
Wolverine Trading's DXCM Position: Q3 2025 in Review
Wolverine Trading increased its DexCom (DXCM) stake by 165% in Q3 2025, buying an estimated $4.1M and bringing the position to 83,167 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1321.
Wolverine Trading first reported a position in DXCM in Q4 2016 and has held it in 28 quarters since. The position peaked at $30.6M in Q3 2021. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.
- Wolverine Trading held 83,167 shares of DexCom worth $5.53M as of Q3 2025.
- Wolverine Trading bought 51,783 DexCom shares in Q3 2025, an estimated $4.1M.
- DexCom made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1321 holding.
- Wolverine Trading first reported a position in DexCom in Q4 2016 and has held it in 28 quarters since.
- Wolverine Trading's DexCom position peaked at $30.6M in Q3 2021.
- 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.